Akèy › Maladi poumon entèstisyèl › Kalifòni › Los Angeles
Etid klinik pou Maladi poumon entèstisyèl nan Los Angeles, CA
14 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Ap rekriteFaz 3
- University of Southern California, Los Angeles
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Ap rekriteFaz 3
- University of California Los Angeles, Los Angeles
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 3
- USA010, Los Angeles
- USA023, Los Angeles
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Ap rekriteFaz 3
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Ap rekriteFaz 3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Ap rekriteFaz 2
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Ap rekriteFaz 3
- David Geffen School of Medicine at UCLA, Los Angeles
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteEtid obsèvasyon
- Cedars-Sinai Medical Center, Los Angeles
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Ap rekriteEtid obsèvasyon
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Ap rekriteFaz 3
- Peter Morton Medical Building, Los Angeles
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Ap rekriteFaz 2
- Keck School of Medicine of USC, Los Angeles
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Ap rekriteFaz 2
- aTyr Investigative Site, Los Angeles
Etid Maladi poumon entèstisyèl nan lòt vil
- New York City, NY18 etid
- Philadelphia, PA16 etid
- Charleston, SC13 etid
- Kansas City, KS13 etid
- Durham, NC13 etid
- Chicago, IL12 etid
- Houston, TX12 etid
- Aurora, CO11 etid
- Ann Arbor, MI11 etid
- Salt Lake City, UT9 etid
- Dallas, TX9 etid
- Boston, MA9 etid
Lòt etid nan Los Angeles
- Kansè Poumon ki pa ti selil87 etid
- Kansè (tout kalite)74 etid
- Kansè nan tete73 etid
- Kansè pwostat61 etid
- Kansè kolorektal59 etid
- Kansè Metastatik57 etid
- Kansè ovè50 etid
- Kansè poumon45 etid
- Karsinòm selil skuamèz tèt ak kou42 etid
- Kansè pankreyas35 etid
- Kansè Endomèt34 etid
- Melanom34 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.